Viewing Study NCT00071656



Ignite Creation Date: 2024-05-05 @ 11:31 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00071656
Status: COMPLETED
Last Update Posted: 2013-08-09
First Post: 2003-10-29

Brief Title: Psychosocial Treatment for Attention Deficit Hyperactivity Disorder ADHD Type I
Sponsor: University of California San Francisco
Organization: University of California San Francisco

Study Overview

Official Title: Psychosocial Treatment for ADHD Inattentive Type I
Status: COMPLETED
Status Verified Date: 2013-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to develop and implement a treatment that focuses on behaviors to reduce symptom severity and functional impairment in patients with Attention Deficit Hyperactivity Disorder Predominantly Inattentive Type ADHD-I The long-term goal of this study is to apply the treatment to larger-scale trials to determine its effectiveness and generalizability
Detailed Description: ADHD-I is a highly prevalent and serious childhood disorder that affects academic and social development The symptoms of ADHD-I differ from those of the well-studied ADHD Combined Type Unfortunately studies of psychosocial interventions for ADHD-I are currently unavailable Effective treatments for ADHD-I are still needed

Participants are randomly assigned to receive either a behavioral intervention or treatment as usual for 10 to 12 weeks The behavioral intervention includes parent and child skill development groups family meetings and consultation with the childs teacher to address attention problems and areas of impairment at home and school Parent and child interviews teacher and child ratings and psychoeducational testing are used to assess participants Participants are assessed post-treatment and at a 2-month follow-up visit

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
DSIR CT-S US NIH GrantContract None httpsreporternihgovquickSearchR21MH065927
R21MH065927 NIH None None